A special focus on the vaccine industry.  


Home
VacZine Analytics is an established strategic research consultancy based in the United Kingdom.

We provide high-quality disease and commercial analysis to those working within or in collaboration with the vaccine industry.

Our key focus is helping clients build the case for developing new vaccines

Latest Research
Seasonal influenza vaccines forecast June '16 (NEW)
RSV vaccines forecast Mar '16
Zika virus vaccines forecast Feb '16
Shigella vaccines forecast Jan' 16
Rhinovirus vaccines forecast Jan '16
Helicobacter pylori vaccines forecast Dec '15
E.coli (ExPEC) vaccines forecast Nov '15
Biodefense vaccines forecast Sept '15
Epstein-barr virus vaccines forecast June '15
Human metapneumovirus vaccines forecast May '15
Ebola virus vaccines forecast April '15
HBV vaccines forecast Mar '15
Cholesterol (PCSK9) vaccines forecast Feb '15
Parkinson's disease vaccines forecast Jan '15

Latest Articles
The global influenza vaccine market - where next?
2015 FY - Pfizer grows vaccine industry.
A Zika vaccine - late to the party we must attend.
2015 Q2 - round up of results and R&D.
Human metapneumovirus - why the poor cousin of RSV?
2014 FY Results - vaccine industry, still bumping along.
Top ten vaccine industry events - 2014.
Influenza vaccines - more options but don't lose sight of longer term.
No room for blame after our surprise from Ebola.
54th ICAAC, Washington DC conference - selective innovation won't do!
Pfizer vaccines boosts presence with low risk Baxter acquisitions.
Caribbean Chikungunya outbreak should move vaccine back onto the agenda.
Novartis to the vaccines industry - can we have our money back please?
Bexsero®: good for UK children, Novartis Vaccines and a flat industry.
H7N9, like H5N1 - re-exposes weaknesses in pandemic vaccine development
2013 FY results - QIVs: a highlight in a flat industry.
Latest News
© 2015 VacZine Analytics. All rights reserved. Disclaimer | Privacy | Terms and conditions. We sponsor Group B Strep Support.